Controversial stimulant DMAA – the substance that has caused more doping violations in recent years than any other including blood boosters and steroids – was responsible for just one violation during the 2012 London Olympics.
Controversial ingredient DMAA has been detected in Chinese geranium, according to a new study from Intertek AAC Labs and funded by USPlabs, which challenges other recent studies that demonstrated its absence in the plant.
Vitamin Shoppe has reported a record second quarter with gross profit increasing 16.3% on the same quarter of last year, with the pre- and post-workout category growing consistently despite the ongoing DMAA controversy.
The UK Food Standards Agency (FSA) has warned consumers off pre-workout supplements containing the stimulant DMAA, in reaction to adverse events reported from around the world. But it says the medicines agency must determine if it is an illegal drug or...
The French agency responsible for policing the country’s food supplements market told NutraIngredients today the controversial stimulant DMAA has been prioritised by its 2500 agents in a nationwide crackdown.
Supplement giant GNC - which put its head above the parapet in April to defend DMAA while the rest of the trade kept silent - says it has since “made a very concerted effort to move away from DMAA products in our stores”.
While USPLabs has strongly defended the safety, efficacy and legal status of DMAA - the star ingredient in top-selling pre-workout supplement Jack3d - it has been working on a new variant called Jack3d Micro that excludes the controversial stimulant.
Australia’s medicines regulator – the Therapeutic Goods Administration (TGA) - has added DMAA to its Schedule 9 list of prohibited substances and poisons that includes cannabis, salvia divinorum, GHB, heroin, psilocybin and LSD.
USPLabs has challenged the findings of new research on the source of DMAA and alerted the trade to the imminent publication of data it claims “definitively demonstrates” that the much-maligned stimulant is naturally present in the geranium plant.
If last month’s paper in the Journal of Analytical Toxicology was seen by some observers as the ‘final nail in DMAA’s coffin’, a new paper published in Drug Testing and Analysis this month appears to drive that nail home.
Nutratech - the firm behind patented bitter orange (Citrus aurantium) extract Advantra Z - has seen a surge in enquires from manufacturers looking for alternatives to DMAA in the wake of the FDA’s crackdown on the controversial stimulant.